Investor Relations Corporate Profile Evolus is a medical aesthetics company focused on providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. FINANCIAL NEWS August 17, 2018 Evolus Granted Approval of DWP-450 by Health Canada August 15, 2018 Evolus Expands Role of Chief Medical Officer Rui Avelar, MD with Appointment as Head of R&D August 15, 2018 Evolus, Inc. Announces Full Exercise and Closing of Underwriters’ Overallotment Option View all EVENTS Q2 2018 Evolus Earnings Conference Call Aug 2, 2018 at 8:30 AM EDT JMP Securities Life Sciences Conference Jun 20, 2018 at 9:00 AM EDT Cantor 2018 Dermatology & Aesthetics Summit Jun 19, 2018 at 12:00 PM EDT View all PRESENTATION June 2018 Investor Presentation
August 15, 2018 Evolus Expands Role of Chief Medical Officer Rui Avelar, MD with Appointment as Head of R&D
August 15, 2018 Evolus, Inc. Announces Full Exercise and Closing of Underwriters’ Overallotment Option
